Gold, David V. External Entity

Publications

Sort by

Selected publications

  • Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial.  Cancer2012 Academic Article GET IT

Other